PUBLISHER: QYResearch | PRODUCT CODE: 1862277
PUBLISHER: QYResearch | PRODUCT CODE: 1862277
The global market for Pen Needles was estimated to be worth US$ 1385 million in 2024 and is forecast to a readjusted size of US$ 2118 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Pen Needles cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
A pen needle is a disposable, minimally invasive injection device designed to be used with insulin pens, GLP-1 receptor agonist pens, recombinant biologics, and other injectable drug delivery systems for the treatment of chronic conditions such as diabetes, obesity, and rheumatoid arthritis. It consists of a needle tube, cap, inner protective guard, and threaded hub, typically manufactured from precision stainless steel with advanced laser sharpening and lubrication technologies to reduce penetration resistance, providing a more precise, comfortable, and safe injection experience. With the rising prevalence of diabetes and obesity, as well as increasing demand for self-administration and home-based therapies, pen needles have become an essential consumable in chronic disease management. The market is not only driven by insulin growth but also accelerated by the surge in GLP-1 and biologics injections, making it a strategic focus for leading medical device companies.In 2024, global pen needle production reached approximately 11733 million units, with an average global market price of around US$ 118.1 per k unit.
The pen needle market is experiencing rapid growth, fueled by surging global demand for chronic disease treatments, particularly for diabetes and obesity. According to the International Diabetes Federation (IDF), the number of people with diabetes surpassed 540 million in 2024 and is expected to reach nearly 640 million by 2030. The widespread adoption of GLP-1 weight-loss drugs is expanding the non-insulin injection market, positioning pen needles as a high-growth category for pharmaceutical and medical device companies. Policies in many countries encourage home self-injection to alleviate healthcare system burdens. Pharmaceutical companies are driving innovations in drug delivery, and pen needle technology is evolving accordingly, from ultra-thin needle tips and painless injection designs to advanced safety features, creating a dynamic market with fast-paced product upgradeDespite its promising outlook, the pen needle industry faces challenges such as raw material price volatility, product homogenization, and regulatory hurdles in international trade. The cost of high-precision stainless steel tubing is influenced by fluctuations in global steel prices and advanced manufacturing processes. Limited differentiation in product design and specifications has led to intense price competition, squeezing margins. Developed markets enforce increasingly strict quality standards, regulatory approvals, and procurement policies, raising barriers to entry and compliance costs. Additionally, the growing reliance on a few pharmaceutical giants dominating GLP-1 and biologics markets creates a relatively stable yet imbalanced competitive landscape. Future demand for pen needles will emphasize personalization, comfort, and value-added features. With the expansion of long-acting insulin, GLP-1 therapies, and biologic injections, the market is diversifying beyond diabetes into obesity management, autoimmune diseases, and rare disorders. Patient experience is a core driver, spurring the development of thinner, shorter needles with silicone lubrication and safety-lock mechanisms to reduce injection anxiety. Digital health solutions and smart drug management systems are also integrating with pen needles, enabling "drug-device ecosystem" offerings. As healthcare systems prioritize home care and self-administration, the high-end pen needle market is poised for growth, with opportunities for global expansion through innovation and strong branding.
Key raw materials for pen needles include medical-grade stainless steel tubing, polypropylene (PP) for needle hubs and caps, and medical silicone lubricants. The precision tubing market is dominated by a few suppliers, such as Nippon Steel & Sumikin Precision, Sandvik, and Kobe Steel, which specialize in high-precision cold-drawing and surface treatment. Plastic materials are mainly supplied by Sinopec, SABIC, and LG Chem, ensuring relatively stable availability, while silicone lubricants are sourced from companies like Dow Corning and Shin-Etsu Chemical. Overall, the pen needle supply chain is highly concentrated, with stainless steel price fluctuations being the primary cost factor; leading manufacturers mitigate risks through long-term procurement contracts and in-house needle tubing production.
This report aims to provide a comprehensive presentation of the global market for Pen Needles, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pen Needles by region & country, by Type, and by Application.
The Pen Needles market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pen Needles.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pen Needles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pen Needles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pen Needles in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.